(IBRX) Immunitybio - Performance -57.1% in 12m
IBRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-76.77%
#121 in Peer-Group
Rel. Strength
7.14%
#7149 in Stock-Universe
Total Return 12m
-57.08%
#143 in Peer-Group
Total Return 5y
-78.88%
#92 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 6.70 USD |
| 52 Week Low | 1.89 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 56.49 |
| Buy/Sell Signal +-5 | -0.23 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IBRX (-57.1%) vs XBI (-6.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.92% | 72.5% | 80.4% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.48% | -6.85% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.26% | -3.11% | 38.6% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.07% | 32.1% | -2.24% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.19% | -6.83% | 5.89% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.6% | 39.2% | -5% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.71% | 54.5% | -7.69% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.98% | 29.3% | 17.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: IBRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IBRX
| Total Return (including Dividends) | IBRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -18.90% | 4.28% | 4.37% |
| 3 Months | 7.31% | 17.36% | 14.09% |
| 12 Months | -57.08% | -6.86% | 13.68% |
| 5 Years | -78.88% | -21.19% | 112.88% |
| Trend Score (consistency of price movement) | IBRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -85.5% | 13.1% | 83.6% |
| 3 Months | 53% | 79.4% | 97.2% |
| 12 Months | -77.8% | -87.1% | 45.7% |
| 5 Years | -71.7% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th10.00 | -22.22% | -22.29% |
| 3 Month | %th31.50 | -8.56% | -5.94% |
| 12 Month | %th29.50 | -53.92% | -62.24% |
| 5 Years | %th56.00 | -73.20% | -90.08% |
FAQs
Does Immunitybio (IBRX) outperform the market?
No,
over the last 12 months IBRX made -57.08%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.86%.
Over the last 3 months IBRX made 7.31%, while XBI made 17.36%.
Performance Comparison IBRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IBRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.1% | -23.3% | 7.1% | -71% |
| US NASDAQ 100 | QQQ | 4.7% | -23.8% | 5.3% | -69% |
| German DAX 40 | DAX | 2.5% | -20.5% | -5.7% | -91% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.3% | -22.5% | 3.5% | -77% |
| Hongkong Hang Seng | HSI | 6.6% | -22.1% | -13.3% | -95% |
| India NIFTY 50 | INDA | 5.6% | -19.7% | 6.6% | -56% |
| Brasil Bovespa | EWZ | 8.3% | -22.8% | -11.1% | -61% |
IBRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6% | -22.7% | 3% | -81% |
| Consumer Discretionary | XLY | 6.2% | -21.5% | 15.7% | -73% |
| Consumer Staples | XLP | 7.4% | -18.7% | 8.1% | -65% |
| Energy | XLE | 4.4% | -25.1% | 14.1% | -60% |
| Financial | XLF | 6.1% | -22% | 3.8% | -84% |
| Health Care | XLV | 5.6% | -20.4% | 17.4% | -52% |
| Industrial | XLI | 4.5% | -22.7% | 0.4% | -83% |
| Materials | XLB | 5.3% | -23.3% | 4% | -64% |
| Real Estate | XLRE | 6.6% | -18.7% | 8% | -69% |
| Technology | XLK | 4% | -26.7% | 2.2% | -68% |
| Utilities | XLU | 4.9% | -21.1% | 5.4% | -80% |
| Aerospace & Defense | XAR | 4% | -23.6% | -11.5% | -107% |
| Biotech | XBI | 2.1% | -23.2% | 17% | -50% |
| Homebuilder | XHB | 4.5% | -28.2% | 12.2% | -64% |
| Retail | XRT | 5.7% | -21% | 13.3% | -68% |
IBRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.9% | -25.7% | 19.9% | -54% |
| Natural Gas | UNG | 13.6% | -4.7% | 38.2% | -47% |
| Gold | GLD | 6.9% | -18.5% | -7.8% | -97% |
| Silver | SLV | 6.4% | -17.7% | -4.2% | -74% |
| Copper | CPER | -0.7% | -30.7% | -12.3% | -78% |
IBRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.4% | -21% | 11.4% | -55% |
| iShares High Yield Corp. Bond | HYG | 5.8% | -20.5% | 10.2% | -67% |